AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Chao, KC Wang, PH Chang, CC Lai, CR Ng, HT
Citation: Kc. Chao et al., Establishment and characterization of a cell line, MT-213-VGH, isolated from a mixed mullerian tumor of the uterus, ACT CYTOL, 45(5), 2001, pp. 683-690

Authors: Wu, YC Yuan, CC Hung, JH Chao, KC Yen, MS Ng, HT
Citation: Yc. Wu et al., Power Doppler angiographic appearance and blood flow velocity waveforms ininvasive cervical carcinoma, GYNECOL ONC, 79(2), 2000, pp. 181-186

Authors: Twu, NF Juang, CM Yeng, MS Lu, CJ Lai, CZ Chao, KC
Citation: Nf. Twu et al., Treatment of primary pure angiosarcoma of ovary with multiple lung metastases: a case report, EUR J GYN O, 20(5-6), 1999, pp. 383-385

Authors: Chao, KC Chang, CC Yen, MS Wang, PH Ng, HT
Citation: Kc. Chao et al., Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro, GYNECOL OBS, 48(4), 1999, pp. 280-284

Authors: Wang, PH Chao, KC Lin, G Chao, HT Yuan, CC Ng, HT
Citation: Ph. Wang et al., Primary malignant lymphoma of the cervix in pregnancy - A case report, J REPRO MED, 44(7), 1999, pp. 630-632

Authors: Wang, PH Chao, HT Yuan, CC Lee, WL Chao, KC Ng, HT
Citation: Ph. Wang et al., Ovarian tumors complicating pregnancy - Emergency and elective surgery, J REPRO MED, 44(3), 1999, pp. 279-287

Authors: Chao, KC Chang, CC Yeng, MS Twu, NF
Citation: Kc. Chao et al., Effects of retinoic acid on the production of transforming growth factor-beta isoforms in human ovarian adenocarcinoma cell line in vitro, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 191-196

Authors: Twu, NF Chang, CC Chao, KC Yen, MS
Citation: Nf. Twu et al., The expression of p53 gene in cervical and ovarian cancer, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 327-330

Authors: Yeng, MS Juang, CM Twu, NF Chao, KC
Citation: Ms. Yeng et al., Intraperitoneal cisplatin-based chemotherapy versus intravenous cisplatin-based chemotherapy for stage III ovarian cancer with minimal residual disease: 10 years experience, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 331-335
Risultati: 1-9 |